Cargando…

Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study

INTRODUCTION: Malignant pleural effusion (MPE) is associated with poor treatment outcome in patients with NSCLC receiving immune checkpoint inhibitors (ICIs). ICIs and chemotherapy (ICI/Chemo) combination therapy is currently the standard therapy for NSCLC, and some ICI/Chemo regimens for nonsquamou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawachi, Hayato, Tamiya, Motohiro, Taniguchi, Yoshihiko, Yokoyama, Toshihide, Yokoe, Shinya, Oya, Yuko, Imaji, Mihoko, Okabe, Fukuko, Kanazu, Masaki, Sakata, Yoshihiko, Uematsu, Shinya, Tanaka, Satoshi, Arai, Daisuke, Saito, Go, Kobe, Hiroshi, Miyauchi, Eisaku, Okada, Asuka, Hara, Satoshi, Kumagai, Toru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234704/ https://www.ncbi.nlm.nih.gov/pubmed/35769388 http://dx.doi.org/10.1016/j.jtocrr.2022.100355

Ejemplares similares

Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility
por: Fujimoto, Daichi, et al.
Publicado: (2023)

Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study
por: Matsumoto, Kinnosuke, et al.
Publicado: (2021)

Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study
por: Hosoya, Kazutaka, et al.
Publicado: (2021)

Incidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor T790M mutation: A case report
por: Kobe, Hiroshi, et al.
Publicado: (2022)

Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC
por: Kuge, Tomoki, et al.
Publicado: (2023)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
por: Kinehara, Yuhei, et al.
Publicado: (2023)

Bronchial ethanol injection therapy for airway obstruction in lung cancer patients
por: Okabe, Fukuko, et al.
Publicado: (2021)

Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan
por: Edahiro, Ryuya, et al.
Publicado: (2019)

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
por: Fujimoto, Daichi, et al.
Publicado: (2021)

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
por: Morita, Mitsunori, et al.
Publicado: (2020)

The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC
por: Tamiya, Motohiro, et al.
Publicado: (2021)

Quantitative metabolic fluxes regulated by trans-omic networks
por: Ohno, Satoshi, et al.
Publicado: (2022)

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
por: Hofman, Véronique, et al.
Publicado: (2022)

Switching from first or second generation EGFR-TKI to osimertinib in EGFR mutation-positive NSCLC
por: Imamura, Fumio, et al.
Publicado: (2020)

Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study
por: Yamamoto, Yuji, et al.
Publicado: (2020)

Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report
por: Kuge, Tomoki, et al.
Publicado: (2021)

The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter retrospective cohort study
por: Takeda, Yuichiro, et al.
Publicado: (2022)

Chemotherapy plus atezolizumab for a patient with small cell lung cancer undergoing haemodialysis: a case report and review of literature
por: Imaji, Mihoko, et al.
Publicado: (2021)

Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
por: Kaneda, Toshihiko, et al.
Publicado: (2018)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial
por: Tamiya, Motohiro, et al.
Publicado: (2018)

A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related Myocarditis
por: Nishikawa, Tatsuya, et al.
Publicado: (2022)

BE‐23372M, a Novel and Specific Inhibitor for Epidermal Growth Factor Receptor Kinase
por: Tanaka, Seiichi, et al.
Publicado: (1994)

Whole‐body Autoradiography of Tumor‐bearing Hamsters with a New Tumor Imaging Agent, Indium‐111‐labeled Porphyrin
por: Yamazaki, Kosuke, et al.
Publicado: (1988)

Transcriptomic analysis of preovipositional embryonic arrest in a nonsquamate reptile (Chelonia mydas)
por: Gárriz, Angela, et al.
Publicado: (2022)

Relationship of hypoxia-inducible factor 1α and p21(WAF1/CIP1 )expression to cell apoptosis and clinical outcome in patients with gastric cancer
por: Mizokami, Ken, et al.
Publicado: (2006)

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)
por: Watanabe, Satoshi, et al.
Publicado: (2022)

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer
por: Nakao, Keiko, et al.
Publicado: (2019)

Tuberculosis-immune Reconstitution Inflammatory Syndrome
por: Hamada, Satoshi, et al.
Publicado: (2019)

Decompressive laparotomy for abdominal compartment syndrome resulting from severe acute pancreatitis: a case report
por: Ikeda, Shinya, et al.
Publicado: (2019)

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
por: Hayashi, Hidetoshi, et al.
Publicado: (2011)

Androgen Receptor Expression in Primary Nonsquamous Cell Rare-Variant Carcinomas of the Head and Neck
por: Rahimi, Siavash, et al.
Publicado: (2017)

Multicenter study of carbon‐ion radiation therapy for nonsquamous cell carcinomas of the oral cavity
por: Ikawa, Hiroaki, et al.
Publicado: (2019)

Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018)

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
por: Tsutani, Yasuhiro, et al.
Publicado: (2018)

Rare Concurrence of Apical Hypertrophic Cardiomyopathy and Effusive Constrictive Pericarditis
por: Okayama, Satoshi, et al.
Publicado: (2011)

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L
por: Sakata, Shinya, et al.
Publicado: (2021)

Effects of Wnt-β-Catenin Signaling and Sclerostin on the Phenotypes of Rat Pheochromocytoma PC12 Cells
por: Morimoto, Eisaku, et al.
Publicado: (2022)

Intrahepatic cholangiocarcinoma in patients with primary sclerosing cholangitis and ulcerative colitis: Two case reports
por: Miyazu, Takahiro, et al.
Publicado: (2023)

Tensile-shear properties of steel-Al adhesively bonded dissimilar joints and the effect of Al plate thickness
por: Uematsu, Yoshihiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_05s5dfmln7ofl8o6ee5cn8n5kr